Their use allows for the identification of 3R/4R tau deposits in AD with high affinity, staging/stratifying AD, and differentiating it from other tauopathies both by the spatial distribution of tracer deposition and by lower affinity and intensity of uptake in 4R tauopathies105,112,113. This evidence concerns the gene MAPT and tauopathy.